Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer

doi 10.21236/ada571316
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple Negative Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

Breast Care
SurgeryOncology
2017English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Luminal-B Breast Cancer and Novel Therapeutic Targets

Breast Cancer Research
Cancer ResearchOncology
2011English

Triple-Negative Breast Cancer

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy